RecruitingNot ApplicableNCT06685744

TeleNEURO-Rehabilitation Systems for Neurodegenerative Conditions: the FIT4TeleNEURO Pragmatic Trial

Effectiveness of TeleNEUROrehabilitation Systems for Timely and Personalized Interventions and Vigilant Care in Neurodegenerative Conditions: the FIT4TeleNEURO Pragmatic Trial


Sponsor

Fondazione Don Carlo Gnocchi Onlus

Enrollment

300 participants

Start Date

Oct 23, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of the FIT4TeleNEURO pragmatic trial is to verify, in real-life care contexts, the superiority in terms of the effectiveness of early rehabilitation intervention with Telerehabilitation (TR) protocols (TR single Approach, task-oriented - TRsA; TR combined approach, task-oriented and impairment-oriented - TRcA) compared to conventional management (Educational treatment, ET). The main questions it aims to answer are: * Are Telerehabilitation protocols more effective than educational treatment? * Is the TRcA treatment more effective than the TRsA? The study investigates the effects of rehabilitation treatment by comparing the two target cases (Multiple Sclerosis - MS and Parkinson's Diseases - PD). Participants will be subjective to: * 3 time-point of assessment (baseline, post-treatment and follow up) with motor, cognitive and quality-of-life measures * A 5-weeks rehabilitation treatment (4 times/week)


Eligibility

Min Age: 25 YearsMax Age: 85 Years

Inclusion Criteria5

  • diagnosis of probable PD according to MDS criteria (Postuma et al., 2015) in staging between 1 and 3 on the Hoehn \& Yahr scale (Goetz et al., 2004) or diagnosis of MS according to the criteria of MC Donald 2010 (Polman et al., 2011) with disability level at the Expanded Disability Status Scale EDSS (Kurtzke, 1983) ≤ 4.5;
  • age between 25 and 85 years;
  • preserved cognitive level at the Montreal Cognitive Assessment test (MoCA test \>15.5) (Santangelo et al., 2015);
  • no rehabilitation program in place at the time of enrolment;
  • stable drug treatment (last three month) with L-Dopa or dopamine agonists (PD group) or Disease Modifying Therapies (DMTs) (MS group).

Exclusion Criteria8

  • presence of comorbidities that might prevent patients from undertaking a safe home program or determining clinical instability (i.e., severe orthopedic or severe cognitive deficits);
  • presence of major psychiatric complications or personality disorders;
  • presence of severe impairment of visual and/or acoustic perception;
  • falls resulting in injuries or more than 2 falls in the 6 months prior to recruitment (PD and MS groups).
  • pregnancy
  • relapse ongoing/at least 3 months since the last relapse (MS group);
  • presence of "frequent" freezing as recorded at the administration of Section II (daily life activity) of the UPDRS (score ≥ 3) (PD group);
  • EDSS-FS (cerebellar function) ≥ 3 (MS group).

Interventions

DEVICETelerehabilitation_TRsA

Frequency: 5 weeks (4 sessions/week) of Telerehabilitation intervention provided according to a mixed model (3 asynchronous sessions + 1 synchronous session/week); Intensity: customized according to the patient's functional abilities (system's feedback); Time: 50 minutes/session; Type: exercises aimed at improving functional mobility and physical capacity according to a Task-oriented approach.

BEHAVIORALEducational treatment

Home rehabilitation indications according to a conventional approach, customized according to the disease.

DEVICETelerehabilitation_TRcA

Frequency: 5 weeks (4 sessions/week) of Telerehabilitation intervention provided according to a mixed model (3 asynchronous sessions + 1 synchronous session/week); Intensity: customized according to the patient's functional abilities (system's feedback); Time: 50 minutes/session; Type: a combination of exercises aimed at improving functional mobility and physical capacity according to a Task-oriented approach together with exercises aimed at recovering muscle strength (resistance) and improving endurance (endurance) using an Impairment-oriented approach.


Locations(6)

Istituti Clinici Scientifici Maugeri SpA

Bari, Italy

IRCCS Azienda Ospedaliera Universitaria San Martino

Genova, Italy

Centro Riabilitativo Villa Beretta

Lecco, Italy

Fondazione Don Carlo Gnocchi Onlus, IRCCS

Milan, Italy

University of Modena and Reggio Emilia

Modena, Italy

Istituto Neurologico Nazionale IRCCS Casimiro Mondino

Pavia, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06685744


Related Trials